Telesis Bio(TBIO)
$0.010.00 (0.00%)
TBIO
Telesis Bio financials statements
$0.01
At close:0.00 (0.00%)
Want to see TBIO full AI Analyst Report?
Telesis Bio (TBIO) Ratios
140 Followers
Telesis Bio Ratios
TBIO's free cash flow for Q3 2024 was $-7.01M. For the 2024 fiscal year, TBIO's free cash flow was decreased by $-55.00K and operating cash flow was $-6.96M. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.71 | 4.08 | 9.57 | 3.05 | 18.25 |
| Quick Ratio | 3.22 | 3.92 | 9.33 | 2.95 | 17.84 |
| Cash Ratio | 0.19 | 2.25 | 8.51 | 2.39 | 16.92 |
| Solvency Ratio | -1.07 | -1.31 | -1.47 | -0.32 | -0.16 |
| Operating Cash Flow Ratio | -4.24 | -2.87 | -3.77 | -2.73 | -3.71 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -60.86 | -11.54 | -12.06 |
| Net Current Asset Value | $ -10.52M | $ 20.30M | $ 67.71M | $ -35.14M | $ -14.83M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.26 | 0.15 | 0.31 | 0.12 |
| Debt-to-Equity Ratio | 1.16 | 0.46 | 0.19 | -0.33 | -0.64 |
| Debt-to-Capital Ratio | 0.54 | 0.32 | 0.16 | -0.49 | -1.74 |
| Long-Term Debt-to-Capital Ratio | 0.15 | 0.30 | 0.13 | -0.15 | -1.48 |
| Financial Leverage Ratio | 2.38 | 1.75 | 1.28 | -1.06 | -5.17 |
| Debt Service Coverage Ratio | -13.05 | -22.32 | -18.26 | -7.84 | -2.95 |
| Interest Coverage Ratio | -14.99 | -23.78 | -25.84 | -23.71 | -4.68 |
| Debt to Market Cap | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.25 | 0.79 | 0.64 | 0.31 | 0.15 |
| Net Debt to EBITDA | -0.81 | 0.21 | 1.82 | 0.32 | 4.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.62% | 56.84% | 38.93% | 55.12% | -84.99% |
| EBIT Margin | -162.11% | -169.46% | -340.26% | -263.31% | -141.77% |
| EBITDA Margin | -147.20% | -158.98% | -326.01% | -241.15% | -123.93% |
| Operating Profit Margin | -169.18% | -169.44% | -320.33% | -248.80% | -145.18% |
| Pretax Profit Margin | -173.40% | -176.59% | -352.66% | -273.80% | -172.78% |
| Net Profit Margin | -173.49% | -176.68% | -352.78% | -273.87% | -172.78% |
| Continuous Operations Profit Margin | -173.49% | -176.68% | -352.78% | -273.87% | -172.78% |
| Net Income Per EBT | 100.05% | 100.05% | 100.04% | 100.03% | 100.00% |
| EBT Per EBIT | 102.49% | 104.22% | 110.09% | 110.05% | 119.01% |
| Return on Assets (ROA) | -67.78% | -59.57% | -33.51% | -67.04% | -21.42% |
| Return on Equity (ROE) | -161.57% | -104.09% | -42.91% | 70.74% | 110.65% |
| Return on Capital Employed (ROCE) | -74.79% | -68.50% | -33.21% | -77.04% | -18.83% |
| Return on Invested Capital (ROIC) | -72.66% | -67.86% | -32.64% | -70.06% | -18.51% |
| Return on Tangible Assets | -72.81% | -75.04% | -39.14% | -85.59% | -25.62% |
| Earnings Yield | -22.21% | -7.62% | -0.68% | -0.19% | -0.06% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.60 | 4.69 | 3.01 | 2.90 | 3.22 |
| Payables Turnover | 3.22 | 9.14 | 2.70 | 2.48 | 14.48 |
| Inventory Turnover | 2.62 | 5.38 | 2.85 | 4.91 | 12.48 |
| Fixed Asset Turnover | 0.80 | 3.22 | 1.92 | 1.74 | 5.41 |
| Asset Turnover | 0.39 | 0.34 | 0.09 | 0.24 | 0.12 |
| Working Capital Turnover Ratio | 0.86 | 0.44 | 0.23 | 0.32 | 0.06 |
| Cash Conversion Cycle | 105.03 | 105.74 | 114.05 | 52.80 | 117.36 |
| Days of Sales Outstanding | 79.41 | 77.84 | 121.14 | 125.77 | 113.34 |
| Days of Inventory Outstanding | 139.13 | 67.82 | 128.16 | 74.34 | 29.24 |
| Days of Payables Outstanding | 113.52 | 39.92 | 135.25 | 147.31 | 25.21 |
| Operating Cycle | 218.55 | 145.66 | 249.30 | 200.11 | 142.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.16 | -1.31 | -1.25 | -0.53 | -0.16 |
| Free Cash Flow Per Share | -1.22 | -1.47 | -1.31 | -0.53 | -0.16 |
| Dividend Paid and CapEx Coverage Ratio | -17.51 | -8.66 | -19.79 | -75.40 | -80.89 |
| Capital Expenditure Coverage Ratio | -17.51 | -8.66 | -19.79 | -75.40 | -80.89 |
| Operating Cash Flow Coverage Ratio | -1.01 | -1.81 | -2.12 | -1.85 | -1.34 |
| Operating Cash Flow to Sales Ratio | -1.26 | -1.41 | -3.32 | -2.34 | -1.33 |
| Free Cash Flow Yield | -17.05% | -6.79% | -0.68% | -0.16% | -0.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.50 | -13.13 | -146.30 | -540.44 | -1634.84 |
| Price-to-Sales (P/S) Ratio | 7.81 | 23.20 | 516.12 | 1480.11 | 2824.66 |
| Price-to-Book (P/B) Ratio | 7.28 | 13.67 | 62.78 | -382.31 | -1808.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.86 | -14.74 | -147.84 | -624.53 | -2098.08 |
| Price-to-Operating Cash Flow Ratio | -6.20 | -16.44 | -155.31 | -632.81 | -2124.02 |
| Price-to-Earnings Growth (PEG) Ratio | 1.24 | -0.55 | -1.28 | -2.57 | 18.02 |
| Enterprise Value Multiple | -6.12 | -14.38 | -156.50 | -613.45 | -2275.08 |
| Enterprise Value | 247.71M | 627.42M | 5.63B | 9.73B | 13.55B |
| EV to EBITDA | -6.12 | -14.38 | -156.50 | -613.45 | -2275.08 |
| EV to Sales | 9.00 | 22.87 | 510.19 | 1479.33 | 2819.59 |
| EV to Free Cash Flow | -6.76 | -14.53 | -146.14 | -624.20 | -2094.31 |
| EV to Operating Cash Flow | -7.15 | -16.21 | -153.52 | -632.48 | -2120.20 |
| Tangible Book Value Per Share | 0.82 | 1.01 | 2.53 | -1.07 | -0.34 |
| Shareholders’ Equity Per Share | 0.99 | 1.58 | 3.10 | -0.87 | -0.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.92 | 0.93 | 0.38 | 0.22 | 0.12 |
| Net Income Per Share | -1.59 | -1.65 | -1.33 | -0.62 | -0.20 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.07 | 1.04 | 1.04 | 1.04 | 1.22 |
| Research & Development to Revenue | 0.64 | 0.86 | 1.32 | 1.36 | 0.27 |
| SG&A to Revenue | 0.77 | 0.81 | 1.29 | 0.63 | 0.98 |
| Stock-Based Compensation to Revenue | 0.14 | 0.14 | 0.10 | 0.01 | 0.00 |
| Income Quality | 0.73 | 0.80 | 0.94 | 0.85 | 0.77 |
Currency in USD

